Celcuity LLC

Celcuity LLC

Yahoo Finance • 23 days ago

Most shorted stocks on Wall Street

[short sale] abluecup As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% of shares outst... Full story

Yahoo Finance • last month

Celcuity GAAP EPS of -$1.44 misses by $0.28

* Celcuity press release [https://seekingalpha.com/pr/20619145-celcuity-inc-reports-release-of-second-quarter-2026-financial-results-and-provides-corporate] (CELC [https://seekingalpha.com/symbol/CELC]): Q2 GAAP EPS of -$1.44 misses by $... Full story

Yahoo Finance • 2 months ago

Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tumor indications, tod... Full story

Yahoo Finance • 2 months ago

Most and least shorted mid- to mega-cap healthcare stocks at the end of July

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images Short interest data from late July 2026 highlights deeply divided investor sentiment across the healthcare sector. S... Full story

Yahoo Finance • 2 months ago

CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Celcuity Inc. on Behalf of Celcuity Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Celcuity (CELC) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Celcuity and would like to di... Full story

Yahoo Finance • 2 months ago

CELC INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Celcuity Inc. (“Celcuity” or the “Company”) (Nasdaq: CELC). The investigation concerns whether the Company and/or m... Full story

Yahoo Finance • 2 months ago

Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data

(RTTNews) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks. Positive data readouts spanned... Full story

Yahoo Finance • 2 months ago

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and fulvestrant andREVTORPY... Full story

Yahoo Finance • 4 months ago

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor... Full story

Yahoo Finance • 4 months ago

Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial

Celcuity (CELC) said Tuesday that detailed results from the Phase 3 Viktoria-1 trial showed its inve PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More

Soleus Capital Management disclosed a significant buy of Vericel(NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average pricing—according to a May 14, 2026, SEC filing. What... Full story

Yahoo Finance • 4 months ago

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase

On May 15, 2026, Boxer Capital Management disclosed a new position in Corvus Pharmaceuticals(NASDAQ:CRVS), acquiring 1,100,000 shares in the first quarter for an estimated $17.55 million based on quarterly average pricing. What happened... Full story

Yahoo Finance • 4 months ago

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally

Boxer Capital Management increased its stake in Kodiak Sciences(NASDAQ:KOD) during the first quarter, adding 225,000 shares in a transaction estimated at $5.81 million based on quarterly average pricing, according to a May 15, 2026, SEC fi... Full story

Yahoo Finance • 4 months ago

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares

On May 15, 2026, Boxer Capital Management disclosed a purchase of 1,241,000 Vir Biotechnology(NASDAQ:VIR) shares, an estimated $9.89 million trade based on quarterly average pricing. What happened According to a Securities and Exchange C... Full story

Yahoo Finance • 4 months ago

Celcuity outlines VIKTORIA-2 expansion while targeting July 17 FDA decision for gedatolisib

Earnings Call Insights: Celcuity (CELC) Q1 2026 MANAGEMENT VIEW * CEO Brian Sullivan said, "We continue to make great progress as we prepare for the potential approval and commercial launch of gedatolisib in the third quarter," and add... Full story

Yahoo Finance • 4 months ago

Celcuity (CELC) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, May 14, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer and Co-Founder — Brian F. SullivanChief Financial Officer — Vicky HahneChief Medical Officer — Igor GorbachevskyChief... Full story

Yahoo Finance • 4 months ago

After-Hours Earnings Report for May 14, 2026 : AMAT, CELC, BOOT, NN, TMC, USAS, STNE, DLO, RUM, UAMY, GLOB, NNE

The following companies are expected to report earnings after hours on 05/14/2026. Visit our Earnings Calendar for a full list of expected earnings releases. Applied Materials, Inc. (AMAT)is reporting for the quarter ending April 30, 2... Full story

Yahoo Finance • 5 months ago

Stocks Turn Lower as Middle East Tensions Rise

The S&P 500 Index ($SPX) (SPY) today is down -0.35%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.75%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.23%.  June E-mini S&P futures (ESM26) are down -0.44%, and June E-mini Na... Full story

Yahoo Finance • 5 months ago

Stocks Mixed on Middle East Tensions and Solid Corporate Earnings

The S&P 500 Index ($SPX) (SPY) today is down -0.04%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.42%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.19%.  June E-mini S&P futures (ESM26) are down -0.05%, and June E-mini Nasd... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Berkshire, AMD, Circle, FedEx, UPS & more

Check out the companies making the biggest moves in midday trading. Logistics firms — Shares of logistics companies were under pressure after Amazon said it would launch Amazon Supply Chain Services , its own freight, distribution, fulfill... Full story